|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.3 EGP | 0.00% |
|
0.00% | -8.00% |
MINAPHARM Pharmaceuticals reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EGP 3,005.35 million compared to EGP 2,361.01 million a year ago. Net income was EGP 466.41 million compared to EGP 300.78 million a year ago.
Basic earnings per share from continuing operations was EGP 36.42 compared to EGP 23.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.00% | 4.73Cr | |
| +20.92% | 4.44TCr | |
| +24.60% | 2.3TCr | |
| +18.00% | 1.51TCr | |
| +13.18% | 1.31TCr | |
| +44.42% | 1.19TCr | |
| -8.33% | 698.92Cr | |
| -0.05% | 678.76Cr | |
| -8.87% | 572.55Cr | |
| +12.22% | 551.54Cr |
MINAPHARM PHARMACEUTICALS 